Osteoporosis Drugs
November 20, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Skeletal Stem Cells Control Effects of Aging; Pain Reprocessing Therapy Offers Alternative To Painkillers; New Dangers Of Aspartame Uncovered
This month’s Save Our Bones Bulletin brings you breaking news from the realms of stem cell research, mental approaches to physical pain, and a shocking revelation regarding a widely used … Continue Reading →
September 4, 2023 by Vivian Goldschmidt, MA
How Osteoporosis Drugs Cause Disruptions Of Vital Communication Between Bone Cells
Our bones are maintained through a continuous cycle of remodeling. Specialized cells called osteoblasts and osteoclasts are responsible for creating new bone and resorbing old bone, respectively. A scientific study … Continue Reading →
August 22, 2023 by Vivian Goldschmidt, MA
Alert! Scientists Repeat Old Mistakes Attempting To Create A New Osteoporosis Drug
A recent study has unveiled a new osteoporosis drug under development. However, the direction the researchers are taking closely resembles an existing osteoporosis drug: Evenity (romosozumab). The researchers promote their … Continue Reading →
August 14, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Compound Could Become Next Osteoporosis Drug; A Robotic Pill That Delivers Injectable Drugs; Hip Fracture Rates Decline, But Total Hip Fractures To Increase
This month’s bulletin starts off with a warning. Medical researchers have announced the development of yet another osteoporosis drug. We’ll look at the details and what to expect. Then we’ll … Continue Reading →
August 9, 2023 by Vivian Goldschmidt, MA
Which Is More Effective: Diet Or Drugs?
Today we’ll be tackling one of the most confounding and troubling trends in modern medicine. Scientific studies have confirmed again and again that for many ailments and conditions, dietary changes … Continue Reading →
June 26, 2023 by Vivian Goldschmidt, MA
Alert: Deadly Side Effect Of Osteoporosis Drug Exposed
A study led by the University of Bristol in the UK has found that the mechanism of action of the osteoporosis drug romosozumab (Evenity) increases the risk of heart attack … Continue Reading →
May 8, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Bisphosphonate Risk Calculator; Study Compares Fracture Prediction Tools; Tryptophan And Bone-Muscle Communication
This month we take a deep dive into a range of research relating to bone health and the future of osteoporosis interventions. First, we’ll look at a new initiative to … Continue Reading →
March 13, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Second Largest US Physician Group Still Serving Big Pharma; New Osteoporosis Drug In The Works; Almonds Show Exercise-Related Benefits
In this month’s Bulletin, we highlight the continued influence of Big Pharma on the Medical Establishment, yet there are also encouraging signs of a more natural approach to achieving wellness. … Continue Reading →
February 6, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Osteoporosis Drug In The Works; A Vitamin Treats Depression; New Corneal Implant
This month, we bring you three recent studies, all about healthcare choices that are (or may soon be) available. First, you’ll hear about the latest attempt to create a new … Continue Reading →
January 30, 2023 by Vivian Goldschmidt, MA
Drug-Induced Osteoporosis: Could Your Medications Be Harming Your Bones?
Many commonly prescribed medications cause bone loss and can lead to osteoporosis. Furthermore, doctors are often unaware that the drugs they prescribe can have this effect. Once again, it’s incumbent … Continue Reading →